HSBC Holdings plc Analysts Give AstraZeneca plc (AZN) a GBX 4,100 Price Target
HSBC Holdings plc set a GBX 4,100 ($53.39) price objective on AstraZeneca plc (LON:AZN) in a research note released on Tuesday morning. The firm currently has a sell rating on the biopharmaceutical company’s stock.
AZN has been the subject of a number of other research reports. Morgan Stanley reiterated an overweight rating and set a GBX 5,600 ($72.93) price target on shares of AstraZeneca plc in a research report on Friday, June 23rd. Deutsche Bank AG reissued a buy rating on shares of AstraZeneca plc in a research note on Monday, May 22nd. Shore Capital reaffirmed a sell rating on shares of AstraZeneca plc in a research report on Thursday, May 4th. Barclays PLC reaffirmed an overweight rating and set a GBX 6,000 ($78.14) target price on shares of AstraZeneca plc in a research report on Monday, June 5th. Finally, Liberum Capital reaffirmed a buy rating and set a GBX 5,500 ($71.62) target price on shares of AstraZeneca plc in a research report on Wednesday, June 14th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of GBX 4,932.67 ($64.24).
AstraZeneca plc (LON:AZN) traded down 1.27% during midday trading on Tuesday, hitting GBX 4506.00. The stock had a trading volume of 2,260,915 shares. The firm’s market cap is GBX 57.05 billion. AstraZeneca plc has a one year low of GBX 3,996.00 and a one year high of GBX 5,520.00. The stock has a 50-day moving average price of GBX 5,022.16 and a 200 day moving average price of GBX 4,861.45.
The company also recently disclosed a dividend, which will be paid on Monday, September 11th. Stockholders of record on Thursday, August 10th will be issued a dividend of GBX 68.90 ($0.90) per share. This represents a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 10th.
In other news, insider Nazneen Rahman acquired 39 shares of AstraZeneca plc stock in a transaction dated Thursday, July 27th. The stock was bought at an average price of GBX 4,370 ($56.91) per share, for a total transaction of £1,704.30 ($2,219.43).
AstraZeneca plc Company Profile
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.
Receive News & Ratings for AstraZeneca plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc and related companies with MarketBeat.com's FREE daily email newsletter.